Preimplantation genetic diagnosis (PGD) is a diagnostic technique used as supplement of the in vitro fertilization that allows genetically to analyze the embryos in the early stages of their development and transfer to the uterus embryos classified as unfit (no genetic damage). The objective is to ensure healthy offspring and avoid the transmission of any disease, chromosomal abnormality or genetic mutation.
PGD requires an exhaustive study by our team of doctors, biologists and geneticists, as well as the establishment of an individualized diagnostic and therapeutic strategy. Next, the couple must undergo in vitro fertilization treatment to grow the embryos to the blastocyst stage, when we will embryo biopsy.
Embryo biopsy:
each embryo is extracted a cell to study their chromosomes. The embryos diagnosed as healthy (no chromosomal abnormalities) may be transferred to the uterus for an evolutionary and normal pregnancy.
The DGP ensures healthy offspring. Every we know more chromosomal abnormalities that cause hereditary diseases. These alterations and can be detected in the embryo. In the list of indications of subsidiaries diseases, the preimplantation genetic diagnosis, reflects all the diseases that can be diagnosed. If you are interested in obtaining information about a disease that is not on the following list, contact us. Our geneticists are in constant innovation and research.
The DGP is indicated when genetic diagnosis is technically possible, its reliability is high, the chances of success are acceptable and assisted reproduction techniques are feasible.